Genentech To Acquire AC Immune’s Beta-Amyloid Antibodies For Alzheimer’s Research
The biotech will pay more than $300 million for preclinical conformation-specific antibodies against beta-amyloid.
The biotech will pay more than $300 million for preclinical conformation-specific antibodies against beta-amyloid.